The elastomeric infusion pumps market size has grown strongly in recent years. It will grow from $1.16 billion in 2025 to $1.27 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to growth in chronic disease treatment needs, increasing use of infusion-based therapies, expansion of hospital outpatient services, rising demand for pain management solutions, improved availability of elastomeric pump devices.
The elastomeric infusion pumps market size is expected to see strong growth in the next few years. It will grow to $1.8 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing preference for homecare treatment models, rising demand for chemotherapy outside hospital settings, growth in ambulatory surgical centers, increasing healthcare focus on patient mobility and comfort, rising healthcare expenditure on infusion therapies. Major trends in the forecast period include rising adoption of home-based infusion therapy, growing preference for portable and disposable pumps, increasing use in pain management treatments, shift toward outpatient and ambulatory care infusions, rising demand for simplified drug delivery devices.
The rising number of hospitalized patients is anticipated to boost the growth of the elastomeric infusion pump market. Hospitalized patients require medical treatment and care, which often involves ongoing monitoring and specific interventions. With advances in medical technology enabling more complex and effective treatments, there has been an increase in hospital admissions for surgeries and procedures. Elastomeric infusion pumps are designed to allow patients to receive necessary medications, such as antibiotics, pain management, or chemotherapy, at home rather than in the hospital. This capability supports early discharge, helping to free up hospital beds and reduce hospital occupancy rates. For example, in August 2025, according to a report published by the National Health Service (NHS), a UK-based government department, there were 552,592 emergency admissions, representing a 1.2% increase compared to December 2023. This growing number of hospitalizations is expected to drive the elastomeric infusion pump market.
The rising healthcare expenditure is expected to drive the growth of the elastomeric infusion pumps market in the coming years. Healthcare expenditure refers to the total financial resources spent by individuals, organizations, or governments on preventing, treating, and managing health conditions. Spending is increasing due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often involve higher costs, contributing to greater overall healthcare spending. Higher healthcare expenditure supports the adoption of elastomeric infusion pumps by enabling hospitals and home-care providers to invest in advanced devices, access specialty therapies, and ensure proper training and maintenance. For example, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, U.S. healthcare expenditures rose by 7.5% in 2023, reaching $4.9 trillion, or approximately $14,570 per individual. Consequently, rising healthcare expenditure is fueling growth in the elastomeric infusion pumps market.
In December 2024, Nipro Trading (Shanghai) Co., Ltd., a Japan-based medical device company, acquired Sichuan Pure Science and Technology Co., Ltd. for an undisclosed amount. Through this acquisition, Nipro Trading aims to strengthen its dialysis solutions portfolio, enhance supply chain capabilities, expand its presence in the Chinese dialysis equipment market, and improve long-term service offerings and operational efficiency. Sichuan Pure Science and Technology Co., Ltd. is a China-based medical device company that manufactures elastomeric infusion pumps.
Major companies operating in the elastomeric infusion pumps market are Baxter International Inc., Medline Industries, B. Braun Melsungen AG, Nipro Corporation, Avanos Medical Inc., Vygon SAS, pfm medical gmbh, Integrated Medical Systems Inc., Preferred Medical, Leventon S.A.U, Tuoren Medical, Eitan Medical, PROMECON GmbH, Epic Medical, Promecon Medical, Ace Medical Devices, Gamastech, Adria Med, Heka Healthcare, Beijing KellyMed Co. Ltd.
North America was the largest region in the elastomeric infusion pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the elastomeric infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the elastomeric infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the elastomeric infusion pumps market by increasing the cost of imported elastomeric materials, medical-grade plastics, and precision manufacturing components. These effects are most evident across continuous and variable rate pump segments, particularly in regions dependent on cross-border medical device supply chains such as Asia-Pacific and Europe. Higher tariffs have moderately increased procurement costs for hospitals and home care providers. At the same time, tariffs are encouraging localized manufacturing, alternative material sourcing, and supply chain diversification, supporting long-term market stability.
The elastomeric infusion pumps market research report is one of a series of new reports that provides elastomeric infusion pumps market statistics, including elastomeric infusion pumps industry global market size, regional shares, competitors with a elastomeric infusion pumps market share, detailed elastomeric infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the elastomeric infusion pumps industry. This elastomeric infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Elastomeric infusion pumps are medical devices designed for the controlled delivery of medications or fluids over a specified duration. They are appreciated for their simplicity, portability, and user-friendliness, making them valuable in both hospital and home care environments. These pumps facilitate treatment outside clinical settings, offering patients greater mobility and flexibility during infusion therapy.
The primary types of elastomeric infusion pumps are continuous-rate and variable-rate pumps. Variable-rate pumps allow healthcare providers to adjust the infusion rates by altering the pressure within the elastomeric balloon or using different flow restrictors, ensuring treatment is customized to meet individual patient needs. These pumps are utilized in various treatments, including pain management, antibiotics or antivirals, chemotherapy, and more, and are employed across different settings such as hospitals, ambulatory surgical centers, home care environments, and clinics.
The elastomeric infusion pumps market consists of sales of tubing sets, medication reservoirs, filters, needles and catheters, connectors, and adaptors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The elastomeric infusion pumps market size is expected to see strong growth in the next few years. It will grow to $1.8 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing preference for homecare treatment models, rising demand for chemotherapy outside hospital settings, growth in ambulatory surgical centers, increasing healthcare focus on patient mobility and comfort, rising healthcare expenditure on infusion therapies. Major trends in the forecast period include rising adoption of home-based infusion therapy, growing preference for portable and disposable pumps, increasing use in pain management treatments, shift toward outpatient and ambulatory care infusions, rising demand for simplified drug delivery devices.
The rising number of hospitalized patients is anticipated to boost the growth of the elastomeric infusion pump market. Hospitalized patients require medical treatment and care, which often involves ongoing monitoring and specific interventions. With advances in medical technology enabling more complex and effective treatments, there has been an increase in hospital admissions for surgeries and procedures. Elastomeric infusion pumps are designed to allow patients to receive necessary medications, such as antibiotics, pain management, or chemotherapy, at home rather than in the hospital. This capability supports early discharge, helping to free up hospital beds and reduce hospital occupancy rates. For example, in August 2025, according to a report published by the National Health Service (NHS), a UK-based government department, there were 552,592 emergency admissions, representing a 1.2% increase compared to December 2023. This growing number of hospitalizations is expected to drive the elastomeric infusion pump market.
The rising healthcare expenditure is expected to drive the growth of the elastomeric infusion pumps market in the coming years. Healthcare expenditure refers to the total financial resources spent by individuals, organizations, or governments on preventing, treating, and managing health conditions. Spending is increasing due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often involve higher costs, contributing to greater overall healthcare spending. Higher healthcare expenditure supports the adoption of elastomeric infusion pumps by enabling hospitals and home-care providers to invest in advanced devices, access specialty therapies, and ensure proper training and maintenance. For example, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, U.S. healthcare expenditures rose by 7.5% in 2023, reaching $4.9 trillion, or approximately $14,570 per individual. Consequently, rising healthcare expenditure is fueling growth in the elastomeric infusion pumps market.
In December 2024, Nipro Trading (Shanghai) Co., Ltd., a Japan-based medical device company, acquired Sichuan Pure Science and Technology Co., Ltd. for an undisclosed amount. Through this acquisition, Nipro Trading aims to strengthen its dialysis solutions portfolio, enhance supply chain capabilities, expand its presence in the Chinese dialysis equipment market, and improve long-term service offerings and operational efficiency. Sichuan Pure Science and Technology Co., Ltd. is a China-based medical device company that manufactures elastomeric infusion pumps.
Major companies operating in the elastomeric infusion pumps market are Baxter International Inc., Medline Industries, B. Braun Melsungen AG, Nipro Corporation, Avanos Medical Inc., Vygon SAS, pfm medical gmbh, Integrated Medical Systems Inc., Preferred Medical, Leventon S.A.U, Tuoren Medical, Eitan Medical, PROMECON GmbH, Epic Medical, Promecon Medical, Ace Medical Devices, Gamastech, Adria Med, Heka Healthcare, Beijing KellyMed Co. Ltd.
North America was the largest region in the elastomeric infusion pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the elastomeric infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the elastomeric infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the elastomeric infusion pumps market by increasing the cost of imported elastomeric materials, medical-grade plastics, and precision manufacturing components. These effects are most evident across continuous and variable rate pump segments, particularly in regions dependent on cross-border medical device supply chains such as Asia-Pacific and Europe. Higher tariffs have moderately increased procurement costs for hospitals and home care providers. At the same time, tariffs are encouraging localized manufacturing, alternative material sourcing, and supply chain diversification, supporting long-term market stability.
The elastomeric infusion pumps market research report is one of a series of new reports that provides elastomeric infusion pumps market statistics, including elastomeric infusion pumps industry global market size, regional shares, competitors with a elastomeric infusion pumps market share, detailed elastomeric infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the elastomeric infusion pumps industry. This elastomeric infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Elastomeric infusion pumps are medical devices designed for the controlled delivery of medications or fluids over a specified duration. They are appreciated for their simplicity, portability, and user-friendliness, making them valuable in both hospital and home care environments. These pumps facilitate treatment outside clinical settings, offering patients greater mobility and flexibility during infusion therapy.
The primary types of elastomeric infusion pumps are continuous-rate and variable-rate pumps. Variable-rate pumps allow healthcare providers to adjust the infusion rates by altering the pressure within the elastomeric balloon or using different flow restrictors, ensuring treatment is customized to meet individual patient needs. These pumps are utilized in various treatments, including pain management, antibiotics or antivirals, chemotherapy, and more, and are employed across different settings such as hospitals, ambulatory surgical centers, home care environments, and clinics.
The elastomeric infusion pumps market consists of sales of tubing sets, medication reservoirs, filters, needles and catheters, connectors, and adaptors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Elastomeric Infusion Pumps Market Characteristics
3. Elastomeric Infusion Pumps Market Supply Chain Analysis
4. Global Elastomeric Infusion Pumps Market Trends and Strategies
5. Elastomeric Infusion Pumps Market Analysis of End Use Industries
7. Global Elastomeric Infusion Pumps Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Elastomeric Infusion Pumps Total Addressable Market (TAM) Analysis for the Market
9. Elastomeric Infusion Pumps Market Segmentation
10. Elastomeric Infusion Pumps Market Regional and Country Analysis
11. Asia-Pacific Elastomeric Infusion Pumps Market
12. China Elastomeric Infusion Pumps Market
13. India Elastomeric Infusion Pumps Market
14. Japan Elastomeric Infusion Pumps Market
15. Australia Elastomeric Infusion Pumps Market
16. Indonesia Elastomeric Infusion Pumps Market
17. South Korea Elastomeric Infusion Pumps Market
18. Taiwan Elastomeric Infusion Pumps Market
19. South East Asia Elastomeric Infusion Pumps Market
20. Western Europe Elastomeric Infusion Pumps Market
21. UK Elastomeric Infusion Pumps Market
22. Germany Elastomeric Infusion Pumps Market
23. France Elastomeric Infusion Pumps Market
24. Italy Elastomeric Infusion Pumps Market
25. Spain Elastomeric Infusion Pumps Market
26. Eastern Europe Elastomeric Infusion Pumps Market
27. Russia Elastomeric Infusion Pumps Market
28. North America Elastomeric Infusion Pumps Market
29. USA Elastomeric Infusion Pumps Market
30. Canada Elastomeric Infusion Pumps Market
31. South America Elastomeric Infusion Pumps Market
32. Brazil Elastomeric Infusion Pumps Market
33. Middle East Elastomeric Infusion Pumps Market
34. Africa Elastomeric Infusion Pumps Market
36. Elastomeric Infusion Pumps Market Competitive Landscape and Company Profiles
37. Elastomeric Infusion Pumps Market Other Major and Innovative Companies
40. Elastomeric Infusion Pumps Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Elastomeric Infusion Pumps Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses elastomeric infusion pumps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for elastomeric infusion pumps? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The elastomeric infusion pumps market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Continuous Rate Elastomeric Pumps; Variable Rate Elastomeric Pumps2) By Treatment: Pain Management; Antibiotic Or Antiviral; Chemotherapy; Other Treatments
3) By End-User: Hospitals; Ambulatory Surgical Centers; Home Care Settings; Clinics; Other End-Users
Subsegments:
1) By Continuous Rate Elastomeric Pumps: Single-Flow Rate Elastomeric Pumps; Multi-Flow Rate Elastomeric Pumps (Fixed); Infusion Pumps For Pain Management2) By Variable Rate Elastomeric Pumps: Adjustable Flow Rate Elastomeric Pumps; Pumps With Programmable Infusion Rates; Multi-therapy Variable Rate Elastomeric Pumps; Infusion Pumps For Chemotherapy And High-Precision Treatments
Companies Mentioned: Baxter International Inc.; Medline Industries; B. Braun Melsungen AG; Nipro Corporation; Avanos Medical Inc.; Vygon SAS; pfm medical gmbh; Integrated Medical Systems Inc.; Preferred Medical; Leventon S.A.U; Tuoren Medical; Eitan Medical; PROMECON GmbH; Epic Medical; Promecon Medical; Ace Medical Devices; Gamastech; Adria Med; Heka Healthcare; Beijing KellyMed Co. Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Elastomeric Infusion Pumps market report include:- Baxter International Inc.
- Medline Industries
- B. Braun Melsungen AG
- Nipro Corporation
- Avanos Medical Inc.
- Vygon SAS
- pfm medical gmbh
- Integrated Medical Systems Inc.
- Preferred Medical
- Leventon S.A.U
- Tuoren Medical
- Eitan Medical
- PROMECON GmbH
- Epic Medical
- Promecon Medical
- Ace Medical Devices
- Gamastech
- Adria Med
- Heka Healthcare
- Beijing KellyMed Co. Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.27 Billion |
| Forecasted Market Value ( USD | $ 1.8 Billion |
| Compound Annual Growth Rate | 9.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
